颅咽管瘤患者10年体成分与骨密度纵向变化
这项回顾性纵向研究纳入112例颅咽管瘤成人患者,其中86例有两次双能X线吸收测定法(DXA)扫描、中位间隔10.0年。结果显示体质指数(BMI)、脂肪质量指数(FMI)和去脂质量指数(FFMI)基线偏高且随访中升高,FFMI的Z评分及全身、L2-L4、股骨颈骨密度(BMD)Z评分升高;糖皮质激素剂量和放疗与BMD下降相关,生长激素替代治疗(GHRT)与BMD升高相关。
要点
- 颅咽管瘤患者基线BMI、FMI、FFMI偏高,随访中绝对值进一步升高。
- FFMI的Z评分及全身、L2-L4、股骨颈BMD的Z评分随随访升高。
- 糖皮质激素剂量与放疗和BMD下降相关,GHRT与BMD升高相关。
核心结论
- 颅咽管瘤患者BMI、脂肪百分比和FMI的Z评分随时间保持稳定,而FFMI和BMD的Z评分升高。
- 较高糖皮质激素剂量和放疗与BMD丢失相关,GHRT与BMD增加相关。
研究设计与样本
- 回顾性纵向研究,来自荷兰和瑞典两家转诊中心。
- 纳入112例颅咽管瘤患者,其中86例有两次DXA扫描,中位Δtime 10.0年(范围0.4-23.3)。
- 年龄≥18岁,58例(52%)男性,50例(45%)儿童期起病。
主要发现
- BMI从28.8 ± 4.9升至31.2 ± 5.1 kg/m2,P < .001。
- FMI从10.5 ± 3.6升至11.9 ± 3.8 kg/m2,P = .001;FFMI从18.3 ± 3.2升至19.1 ± 3.2 kg/m2,P < .001。
- FFMI Z评分从0.26 ± 1.62升至1.06 ± 2.22,P < .001;脂肪百分比和体成分其他Z评分未增加。
- 全身、L2-L4、股骨颈BMD Z评分平均差异分别为0.61 ± 1.12(P < .001)、0.74 ± 1.73(P < .001)、0.51 ± 1.85(P = .02)。
关键数值与推荐
- ΔZ评分线性回归:股骨颈与GHRT正相关(beta 1.45 [95% CI 0.51-2.39])。
- 股骨颈与放疗负相关(beta -0.79 [-1.49至-0.09])。
- 全身与糖皮质激素剂量负相关(beta -0.06 [-0.09至-0.02]);L2-L4与改善BMD药物负相关(beta -1.06 [-1.84至-0.28])。
临床怎么用
- 对颅咽管瘤患者应长期监测体成分与BMD,关注糖皮质激素剂量和放疗对骨骼的不利影响。
- GHRT可能与BMD Z评分升高相关,临床决策需结合个体情况综合评估。
局限性
- 回顾性设计,仅86例患者有两次DXA扫描,样本量有限。
- 来自两家转诊中心,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Patients with craniopharyngioma suffer from obesity and impaired bone health. Little is known about longitudinal changes in body composition and bone mineral density (BMD). OBJECTIVE: To describe body composition and BMD (change). DESIGN: Retrospective longitudinal study. SETTING: Two Dutch/Swedish referral centers. PATIENTS: Patients with craniopharyngioma (n = 112) with a dual X-ray absorptiometry (DXA) scan available (2 DXA scans, n = 86; median Δtime 10.0 years; range 0.4-23.3) at age ≥ 18 years (58 [52%] male, 50 [45%] childhood onset). MAIN OUTCOME MEASURES: Longitudinal changes of body composition and BMD, and associated factors of ΔZ-score (sex and age standardized). RESULTS: BMI (from 28.8 ± 4.9 to 31.2 ± 5.1 kg/m2, P < .001), fat mass index (FMI) (from 10.5 ± 3.6 to 11.9 ± 3.8 kg/m2, P = .001), and fat free mass index (FFMI) (from 18.3 ± 3.2 to 19.1 ± 3.2 kg/m2, P < .001) were high at baseline and increased. Fat percentage and Z-scores of body composition did not increase, except for FFMI Z-scores (from 0.26 ± 1.62 to 1.06 ± 2.22, P < .001). Z-scores of total body, L2-L4, femur neck increased (mean difference 0.61 ± 1.12, P < .001; 0.74 ± 1.73, P < .001; 0.51 ± 1.85, P = .02). Linear regression models for ΔZ-score were positively associated with growth hormone replacement therapy (GHRT) (femur neck: beta 1.45 [95% CI 0.51-2.39]); and negatively with radiotherapy (femur neck: beta -0.79 [-1.49 to -0.09]), glucocorticoid dose (total body: beta -0.06 [-0.09 to -0.02]), and medication to improve BMD (L2-L4: beta -1.06 [-1.84 to -0.28]). CONCLUSIONS: Z-scores of BMI, fat percentage, and FMI remained stable in patients with craniopharyngioma over time, while Z-scores of FFMI and BMD increased. Higher glucocorticoid dose and radiotherapy were associated with BMD loss and GHRT with increase.
引用
- van Santen SS, Olsson DS, Hammarstrand C, et al. Body Composition and Bone Mineral Density in Craniopharyngioma Patients: A Longitudinal Study Over 10 Years. J Clin Endocrinol Metab. 2020. PMID: 32869850. doi:10.1210/clinem/dgaa607
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。